Skip to main content
. 2020 Feb 28;10(5):861–877. doi: 10.1016/j.apsb.2020.02.009

Figure 1.

Figure 1

Effects of etanercept administration on liver injury parameters disturbed by TP/LPS co-treatment. (A) Schematic presentation of the experimental procedure to testify the effects of etanercept upon TP/LPS-induced hepatotoxicity. (B)–(G) Levels of serum ALT, AST, TBA, Glucose, total protein, and ALB in TP/LPS treated mice, pretreated with etanercept (n = 10). (H) Pictures of liver tissue sections stained by H&E (top panels), analyzed by IHC for MPO (middle panels) or analyzed by PAS (bottom panels) (200 ×). Scale bar = 50 μm. Results were expressed as mean ± SEM and statistical analysis was performed using One-way ANOVA following by Tukey's multiple comparison test. *, #P < 0.05, ***, ##P < 0.01, ***, ###P < 0.001; ns, no statistical difference.